Northpointe Capital LLC Has $5.68 Million Position in Metlife Inc (NYSE:MET)

Northpointe Capital LLC lowered its position in shares of Metlife Inc (NYSE:MET) by 4.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 114,275 shares of the financial services provider’s stock after selling 5,627 shares during the quarter. Metlife accounts for about 1.8% of Northpointe Capital LLC’s investment portfolio, making the stock its 11th biggest holding. Northpointe Capital LLC’s holdings in Metlife were worth $5,676,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MET. Geode Capital Management LLC increased its position in Metlife by 7.4% during the fourth quarter. Geode Capital Management LLC now owns 12,421,536 shares of the financial services provider’s stock worth $509,344,000 after acquiring an additional 856,479 shares during the period. Clearbridge Investments LLC increased its position in Metlife by 2.9% during the first quarter. Clearbridge Investments LLC now owns 11,907,582 shares of the financial services provider’s stock worth $506,906,000 after acquiring an additional 332,510 shares during the period. LSV Asset Management increased its position in Metlife by 1.0% during the first quarter. LSV Asset Management now owns 4,053,327 shares of the financial services provider’s stock worth $172,550,000 after acquiring an additional 41,324 shares during the period. Jennison Associates LLC increased its position in Metlife by 1.3% during the first quarter. Jennison Associates LLC now owns 3,869,086 shares of the financial services provider’s stock worth $164,707,000 after acquiring an additional 51,272 shares during the period. Finally, MERIAN GLOBAL INVESTORS UK Ltd increased its position in Metlife by 57.5% during the first quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 3,642,132 shares of the financial services provider’s stock worth $155,045,000 after acquiring an additional 1,330,398 shares during the period. Hedge funds and other institutional investors own 75.74% of the company’s stock.

A number of equities research analysts have issued reports on the stock. Citigroup set a $42.00 price objective on shares of Metlife and gave the stock a “sell” rating in a research note on Thursday, May 23rd. ValuEngine downgraded shares of Metlife from a “hold” rating to a “sell” rating in a research note on Thursday, August 1st. Deutsche Bank increased their price objective on shares of Metlife from $46.00 to $47.00 and gave the stock a “hold” rating in a research note on Friday, April 12th. Barclays increased their price objective on shares of Metlife from $52.00 to $55.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 22nd. Finally, Zacks Investment Research upgraded shares of Metlife from a “sell” rating to a “hold” rating and set a $51.00 price objective on the stock in a research note on Friday, August 2nd. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $50.91.

MET opened at $46.85 on Wednesday. The firm has a 50 day moving average of $49.61. Metlife Inc has a 1-year low of $37.76 and a 1-year high of $51.16. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.22. The firm has a market cap of $44.94 billion, a P/E ratio of 8.69, a P/E/G ratio of 1.00 and a beta of 1.09.

Metlife (NYSE:MET) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.38 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.07. Metlife had a net margin of 9.28% and a return on equity of 9.75%. The company had revenue of $16.45 billion for the quarter, compared to the consensus estimate of $16.43 billion. During the same period last year, the company posted $1.30 EPS. The firm’s quarterly revenue was down 22.4% compared to the same quarter last year. On average, equities analysts predict that Metlife Inc will post 5.63 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Investors of record on Tuesday, August 6th will be issued a $0.44 dividend. The ex-dividend date of this dividend is Monday, August 5th. This represents a $1.76 dividend on an annualized basis and a yield of 3.76%. Metlife’s dividend payout ratio (DPR) is presently 32.65%.

Metlife Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Read More: What are economic reports?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.